Status:
COMPLETED
Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial
Lead Sponsor:
Yonsei University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
19-85 years
Phase:
PHASE4
Brief Summary
In this prospective open-label randomized trial, 160 patients with elective off-pump coronary artery bypass (OPCAB) surgery were enrolled. After primary suture of aortocoronary anastomosis, if an area...
Detailed Description
\[Patients\] A total of 160 patients were enrolled over a 24-month period in a prospective randomized controlled trial between March 2018 and Feburary 2020. The Institutional Review Board (IRB) at our...
Eligibility Criteria
Inclusion
- patients aged 19 years or older
- undergoing elective OPCAB surgery with multi-vessel coronary artery disease.
Exclusion
- patients were pregnant
- had a known sensitivity to any components of the bovine thrombin preparations or the porcine origin materials.
Key Trial Info
Start Date :
February 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04310150
Start Date
February 5 2018
End Date
March 31 2020
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea